Loss of hypothalamic MCH decreases food intake in amyotrophic lateral sclerosis

[1]  C. Burgess,et al.  The melanin-concentrating hormone system as a target for the treatment of sleep disorders , 2022, Frontiers in Neuroscience.

[2]  A. Musarò,et al.  Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1G93A mice , 2021, British journal of pharmacology.

[3]  G. Gong,et al.  Hypothalamic subregion abnormalities are related to body mass index in patients with sporadic amyotrophic lateral sclerosis , 2021, Journal of Neurology.

[4]  M. Schwaninger,et al.  Multifaceted actions of melanin-concentrating hormone on mammalian energy homeostasis , 2021, Nature Reviews Endocrinology.

[5]  Katharina M. Hembach,et al.  Cytoplasmic FUS triggers early behavioral alterations linked to cortical neuronal hyperactivity and inhibitory synaptic defects , 2021, Nature Communications.

[6]  J. Veldink,et al.  Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: a longitudinal, population-based, case-control study , 2021, The Lancet Neurology.

[7]  G. Halliday,et al.  Loss of the metabolism and sleep regulating neuronal populations expressing orexin and oxytocin in the hypothalamus in amyotrophic lateral sclerosis , 2021, Neuropathology and applied neurobiology.

[8]  V. Rasche,et al.  Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and in human patients , 2020, Translational Neurodegeneration.

[9]  F. Steyn,et al.  Hypothalamus and weight loss in amyotrophic lateral sclerosis. , 2021, Handbook of clinical neurology.

[10]  R. Vandenberghe,et al.  Dipeptide repeat protein and TDP-43 pathology along the hypothalamic–pituitary axis in C9orf72 and non-C9orf72 ALS and FTLD-TDP cases , 2020, Acta Neuropathologica.

[11]  A. Winkler,et al.  Effect of high-caloric nutrition on serum neurofilament light chain levels in amyotrophic lateral sclerosis , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

[12]  P. van Damme,et al.  Amyotrophic lateral sclerosis: a clinical review , 2020, European journal of neurology.

[13]  S. Rossi,et al.  Skeletal-Muscle Metabolic Reprogramming in ALS-SOD1G93A Mice Predates Disease Onset and Is A Promising Therapeutic Target , 2020, iScience.

[14]  W. M. Leevy,et al.  Altered skeletal muscle glucose-fatty acid flux in amyotrophic lateral sclerosis (ALS) , 2020, bioRxiv.

[15]  H. Braak,et al.  Histological correlates of postmortem ultra-high-resolution single-section MRI in cortical cerebral microinfarcts , 2020, Acta Neuropathologica Communications.

[16]  A. Winkler,et al.  Effect of High‐Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis , 2019, Annals of neurology.

[17]  L. H. van den Berg,et al.  Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis , 2019, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[18]  Mohan Bolisetty,et al.  Single-cell transcriptomic analysis of the lateral hypothalamic area reveals molecularly distinct populations of inhibitory and excitatory neurons , 2019, Nature Neuroscience.

[19]  R. Coccurello,et al.  Skeletal-Muscle Metabolic Reprogramming in ALS-SOD1 G93G Mice Predates Disease Onset and is a Promising Therapeutic Target , 2019, SSRN Electronic Journal.

[20]  H. Braak,et al.  Two histological methods for recognition and study of cortical microinfarcts in thick sections , 2018, European journal of histochemistry : EJH.

[21]  Amir I Mina,et al.  CalR: A Web-based Analysis Tool for Indirect Calorimetry Experiments , 2017, bioRxiv.

[22]  N. Wray,et al.  Hypermetabolism in ALS is associated with greater functional decline and shorter survival , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

[23]  G. Nagel,et al.  Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia , 2017, European Journal of Epidemiology.

[24]  G. Nagel,et al.  Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[25]  Ying Sun,et al.  Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis , 2017, Acta Neuropathologica.

[26]  Patricia Bonnavion,et al.  Hubs and spokes of the lateral hypothalamus: cell types, circuits and behaviour , 2016, The Journal of physiology.

[27]  J. Dreyhaupt,et al.  Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis. , 2016, Brain : a journal of neurology.

[28]  Xiang-Dong Fu,et al.  Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss , 2016, The EMBO journal.

[29]  Kevin F. Bieniek,et al.  A truncating SOD1 mutation, p.Gly141X, is associated with clinical and pathologic heterogeneity, including frontotemporal lobar degeneration , 2015, Acta Neuropathologica.

[30]  Jong-Woo Sohn.  Network of hypothalamic neurons that control appetite , 2015, BMB reports.

[31]  A. Echaniz-Laguna,et al.  A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis , 2015, EMBO molecular medicine.

[32]  S. Powell,et al.  TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis , 2014, Acta neuropathologica communications.

[33]  R. Kalb,et al.  Genetically altering organismal metabolism by leptin-deficiency benefits a mouse model of amyotrophic lateral sclerosis. , 2014, Human molecular genetics.

[34]  J. Lou,et al.  Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial , 2014, The Lancet.

[35]  John L. Robinson,et al.  TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord , 2014, Acta Neuropathologica.

[36]  Michael W. Schwartz,et al.  Neurobiology of food intake in health and disease , 2014, Nature Reviews Neuroscience.

[37]  John Q. Trojanowski,et al.  Amyotrophic lateral sclerosis—a model of corticofugal axonal spread , 2013, Nature Reviews Neurology.

[38]  A. Ludolph,et al.  High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: A prospective interventional study , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[39]  Murray Grossman,et al.  Stages of pTDP‐43 pathology in amyotrophic lateral sclerosis , 2013, Annals of neurology.

[40]  H. Braak,et al.  Paraffin sections of 70–100μm: A novel technique and its benefits for studying the nervous system , 2013, Journal of Neuroscience Methods.

[41]  M. Thun,et al.  Premorbid body mass index and risk of amyotrophic lateral sclerosis , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[42]  F. Clavel-Chapelon,et al.  Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis , 2013, Neurology.

[43]  J. Speakman.  Measuring Energy Metabolism in the Mouse – Theoretical, Practical, and Analytical Considerations , 2012, Front. Physiol..

[44]  G. Yeo,et al.  Unraveling the brain regulation of appetite: lessons from genetics , 2012, Nature Neuroscience.

[45]  P. Pilowsky,et al.  Intrathecal melanin-concentrating hormone reduces sympathetic tone and blocks cardiovascular reflexes. , 2012, American Journal of Physiology. Regulatory Integrative and Comparative Physiology.

[46]  Robert V Farese,et al.  A guide to analysis of mouse energy metabolism , 2011, Nature Methods.

[47]  H. Berthoud,et al.  The lateral hypothalamus as integrator of metabolic and environmental needs: From electrical self-stimulation to opto-genetics , 2011, Physiology & Behavior.

[48]  S. Paganoni,et al.  Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis , 2011, Muscle & nerve.

[49]  J. Kassubek,et al.  Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis , 2011, Journal of Neurology.

[50]  P. Preux,et al.  Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[51]  N. Kronfeld-Schor,et al.  Chronic MCH infusion causes a decrease in energy expenditure and body temperature, and an increase in serum IGF-1 levels in mice , 2009, Endocrine.

[52]  J. Desport,et al.  High metabolic level in patients with familial amyotrophic lateral sclerosis , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[53]  V. Meininger,et al.  Dyslipidemia is a protective factor in amyotrophic lateral sclerosis , 2008, Neurology.

[54]  C. Elias,et al.  Melanin-concentrating hormone projections to areas involved in somatomotor responses , 2008, Journal of Chemical Neuroanatomy.

[55]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[56]  P. Andersen,et al.  Overloading of Stable and Exclusion of Unstable Human Superoxide Dismutase-1 Variants in Mitochondria of Murine Amyotrophic Lateral Sclerosis Models , 2006, The Journal of Neuroscience.

[57]  J. Jeon,et al.  MCH-/- mice are resistant to aging-associated increases in body weight and insulin resistance. , 2006, Diabetes.

[58]  P. Preux,et al.  Hypermetabolism in ALS: Correlations with Clinical and Paraclinical Parameters , 2006, Neurodegenerative Diseases.

[59]  J. Loeffler,et al.  Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[60]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[61]  J. Flier,et al.  Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[62]  H. Iwaasa,et al.  Characterization of MCH-mediated obesity in mice. , 2003, American journal of physiology. Endocrinology and metabolism.

[63]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[64]  H. Braak,et al.  Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.

[65]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[66]  J. Holstege,et al.  CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations , 2001, Acta Neuropathologica.

[67]  B. Lowell,et al.  Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. , 2001, The Journal of clinical investigation.

[68]  J. Holstege,et al.  Human Cu/Zn Superoxide Dismutase (SOD1) Overexpression in Mice Causes Mitochondrial Vacuolization, Axonal Degeneration, and Premature Motoneuron Death and Accelerates Motoneuron Disease in Mice Expressing a Familial Amyotrophic Lateral Sclerosis Mutant SOD1 , 2000, Neurobiology of Disease.

[69]  A. Viale,et al.  Structure and expression of the variant melanin-concentrating hormone genes: only PMCHL1 is transcribed in the developing human brain and encodes a putative protein. , 2000, Molecular biology and evolution.

[70]  C E Elger,et al.  Subregional Pathology of the Amygdala Complex and Entorhinal Region in Surgical Specimens From Patients With Pharmacoresistant Temporal Lobe Epilepsy , 2000, Journal of neuropathology and experimental neurology.

[71]  P. Preux,et al.  Nutritional assessment and survival in ALS patients. , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[72]  D. Sautereau,et al.  Nutritional status is a prognostic factor for survival in ALS patients , 1999, Neurology.

[73]  B. Lowell,et al.  Mice lacking melanin-concentrating hormone are hypophagic and lean , 1998, Nature.

[74]  J. Flier,et al.  Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus. , 1998, American journal of physiology. Endocrinology and metabolism.

[75]  J. Morrison,et al.  Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[76]  P. Risold,et al.  Morphofunctional Studies on the Neurons Producing Melanin‐Concentrating Hormone , 1993, Annals of the New York Academy of Sciences.

[77]  J. Flatt.  Importance of nutrient balance in body weight regulation. , 1988, Diabetes/metabolism reviews.

[78]  H. Braak,et al.  On the striate area of the human isocortex. A golgi‐ and pigmentarchitectonic study , 1976, The Journal of comparative neurology.

[79]  J. B. Weir.  New methods for calculating metabolic rate with special reference to protein metabolism , 1949, The Journal of physiology.